HAYWARD, Calif., Oct. 28, 2013 /PRNewswire/ -- Solta Medical, Inc.
(NASDAQ: SLTM), a global leader in the medical aesthetics market,
today announced that it will release its financial results for the
third quarter ended September 30,
2013, after market close on Monday,
November 11, 2013. The Company will also host a
conference call and webcast on Monday,
November 11, 2013, at 4:30 p.m.
Eastern Time (1:30 p.m.
Pacific) to discuss the financial results and current corporate
developments. The dial-in number for the conference call is
877-941-0844 for domestic participants and 480-629-9835 for
international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The Company offers aesthetic energy devices
for skin resurfacing and rejuvenation, acne reduction, body
contouring and skin tightening, as well as tools and accessories to
optimize the latest liposuction techniques. Each brand is an
established category leader, and together comprise of a
comprehensive platform to address a range of aesthetic skin and
body issues. Fraxel® delivers minimally-invasive clinical solutions
to resurface aging and sun damaged skin. Clear + Brilliant® is a
cost-effective, non-ablative laser treatment uniquely designed to
improve skin tone and radiance. Isolaz® acne treatment combines
vacuum and painless broadband light to address a wide variety of
acne types. CLARO® is an FDA-cleared personal care acne device that
uses heat and light to clear skin quickly and naturally. Thermage®
is a non-invasive radiofrequency procedure that improves the
appearance of wrinkles, which can result in smoother, more
contoured skin. Liposonix® is a non-surgical single-treatment
procedure that uses advanced high-intensity focused ultrasound
technology to destroy targeted fat beneath the skin. VASERshape™ is
a complementary non-invasive treatment that combines low frequency,
non-focused ultrasound and lymphatic massage to temporarily reduce
the appearance of cellulite and improve blood circulation with
minimal pain or no downtime. The VASERlipo™ system uses ultrasound
technology to selectively remove unwanted body fat. It includes
VentX® technology that powers an aspiration system for quiet,
efficient removal of fatty tissue and precision vented cannulas to
maximize aspiration efficiency and speed. VASERsmooth™ is a unique
body sculpting add-on tool for use with the VASERlipo system.
PowerX® is a power-assisted liposuction system that uses a unique
rotational motion which can be used with the VASERlipo system or to
enhance traditional liposuction systems. The TouchView® system fits
between the fingers and provides diagnostic imaging of subcutaneous
structures during procedures. Both the VASERlipo system and
traditional liposuction systems can utilize the Origins™ products,
a complete line of custom liposuction infiltration, re-injection
and aspiration cannulas and accessories. More than two and a half
million procedures have been performed with Solta Medical's
portfolio of products around the world.
For more information about Solta, call 1-877-782-2286 or log on
to www.Solta.com.
SOURCE Solta Medical, Inc.